313 related articles for article (PubMed ID: 27802207)
1. APE1 overexpression promotes the progression of ovarian cancer and serves as a potential therapeutic target.
Wen X; Lu R; Xie S; Zheng H; Wang H; Wang Y; Sun J; Gao X; Guo L
Cancer Biomark; 2016 Sep; 17(3):313-322. PubMed ID: 27802207
[TBL] [Abstract][Full Text] [Related]
2. Alterations in the expression of the apurinic/apyrimidinic endonuclease-1/redox factor-1 (APE1/Ref-1) in human ovarian cancer and indentification of the therapeutic potential of APE1/Ref-1 inhibitor.
Zhang Y; Wang J; Xiang D; Wang D; Xin X
Int J Oncol; 2009 Nov; 35(5):1069-79. PubMed ID: 19787261
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of apurinic/apyrimidinic endonuclease 1/redox factor-1 enhances the sensitivity of human pancreatic cancer cells to radiotherapy in vitro.
Chen S; Xiong G; Wu S; Mo J
Cancer Biother Radiopharm; 2013 Mar; 28(2):169-76. PubMed ID: 23268706
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of the DNA repair and redox signaling protein Ape1/Ref-1 blocks ovarian cancer cell and tumor growth.
Fishel ML; He Y; Reed AM; Chin-Sinex H; Hutchins GD; Mendonca MS; Kelley MR
DNA Repair (Amst); 2008 Feb; 7(2):177-86. PubMed ID: 17974506
[TBL] [Abstract][Full Text] [Related]
5. APE1/REF-1 down-regulation enhances the cytotoxic effects of temozolomide in a resistant glioblastoma cell line.
Montaldi AP; Godoy PR; Sakamoto-Hojo ET
Mutat Res Genet Toxicol Environ Mutagen; 2015 Nov; 793():19-29. PubMed ID: 26520369
[TBL] [Abstract][Full Text] [Related]
6. Impact of apurinic/apyrimidinic endonuclease 1/redox factor-1 on treatment response and survival in oral squamous cell carcinoma.
Hsia KT; Liu CJ; Mar K; Lin LH; Lin CS; Cheng MF; Lee HS; Chiu SY
Head Neck; 2016 Apr; 38(4):550-9. PubMed ID: 25482590
[TBL] [Abstract][Full Text] [Related]
7. Silencing of Apurinic/Apyrimidinic Endonuclease 1 Inhibits the Growth and Migration in Ovarian Cancer Cell via Activator-Protein-1 Signaling.
Kong Q; Wang W; Luo L; Sun X
Gynecol Obstet Invest; 2017; 82(2):188-199. PubMed ID: 27553367
[TBL] [Abstract][Full Text] [Related]
8. Lentiviral-mediated short hairpin RNA silencing of APE1 suppresses hepatocellular carcinoma proliferation and migration: A potential therapeutic target for hepatoma treatment.
Zheng ZH; Du W; Li YJ; Gao MQ; Huang AM; Liu JF
Oncol Rep; 2015 Jul; 34(1):95-102. PubMed ID: 25976295
[TBL] [Abstract][Full Text] [Related]
9. APE1 overexpression is associated with cisplatin resistance in non-small cell lung cancer and targeted inhibition of APE1 enhances the activity of cisplatin in A549 cells.
Wang D; Xiang DB; Yang XQ; Chen LS; Li MX; Zhong ZY; Zhang YS
Lung Cancer; 2009 Dec; 66(3):298-304. PubMed ID: 19324449
[TBL] [Abstract][Full Text] [Related]
10. Cytoplasmic Ape1 expression elevated by p53 aberration may predict survival and relapse in resected non-small cell lung cancer.
Wu HH; Chu YC; Wang L; Tsai LH; Lee MC; Chen CY; Shieh SH; Cheng YW; Lee H
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S336-47. PubMed ID: 22688662
[TBL] [Abstract][Full Text] [Related]
11. Apurinic/apyrimidinic endonuclease 1 regulates angiogenesis in a transforming growth factor β-dependent manner in human osteosarcoma.
Jiang X; Shan J; Dai N; Zhong Z; Qing Y; Yang Y; Zhang S; Li C; Sui J; Ren T; Li M; Wang D
Cancer Sci; 2015 Oct; 106(10):1394-401. PubMed ID: 26250694
[TBL] [Abstract][Full Text] [Related]
12. Ape1 regulates WNT/β-catenin signaling through its redox functional domain in pancreatic cancer cells.
Jiang S; Zhu L; Tang H; Zhang M; Chen Z; Fei J; Han B; Zou GM
Int J Oncol; 2015 Aug; 47(2):610-20. PubMed ID: 26081414
[TBL] [Abstract][Full Text] [Related]
13. Small interfering RNA against the apurinic or apyrimidinic endonuclease enhances the sensitivity of human pancreatic cancer cells to gemcitabine in vitro.
Xiong GS; Sun HL; Wu SM; Mo JZ
J Dig Dis; 2010 Aug; 11(4):224-30. PubMed ID: 20649735
[TBL] [Abstract][Full Text] [Related]
14. Experimental study enhancing the chemosensitivity of multiple myeloma to melphalan by using a tissue-specific APE1-silencing RNA expression vector.
Yang ZZ; Chen XH; Wang D
Clin Lymphoma Myeloma; 2007 Jan; 7(4):296-304. PubMed ID: 17324338
[TBL] [Abstract][Full Text] [Related]
15. Bu-Fei decoction and modified Bu-Fei decoction inhibit the growth of non-small cell lung cancer, possibly via inhibition of apurinic/apyrimidinic endonuclease 1.
Jiang ST; Han SY; Pang LN; Jiao YN; He XR; Li PP
Int J Mol Med; 2018 Apr; 41(4):2128-2138. PubMed ID: 29393411
[TBL] [Abstract][Full Text] [Related]
16. Proteomics reveals a therapeutic vulnerability via the combined blockade of APE1 and autophagy in lung cancer A549 cells.
Pan ST; Zhou J; Yang F; Zhou SF; Ren T
BMC Cancer; 2020 Jul; 20(1):634. PubMed ID: 32641008
[TBL] [Abstract][Full Text] [Related]
17. Knock down of the dual functional protein apurinic /apyrimidinic endonuclease 1 enhances the killing effect of hematoporphrphyrin derivative-mediated photodynamic therapy on non-small cell lung cancer cells in vitro and in a xenograft model.
Yang ZZ; Li MX; Zhang YS; Xiang DB; Dai N; Zeng LL; Li ZP; Wang G; Wang D
Cancer Sci; 2010 Jan; 101(1):180-7. PubMed ID: 19860842
[TBL] [Abstract][Full Text] [Related]
18. Reduced apurinic/apyrimidinic endonuclease activity enhances the antitumor activity of oxymatrine in lung cancer cells.
Wang Z; Xu W; Lin Z; Li C; Wang Y; Yang L; Liu G
Int J Oncol; 2016 Dec; 49(6):2331-2340. PubMed ID: 27748797
[TBL] [Abstract][Full Text] [Related]
19. Apurinic endonuclease 1 promotes the cisplatin resistance of lung cancer cells by inducing Parkin‑mediated mitophagy.
Li Z; Wang Y; Wu L; Dong Y; Zhang J; Chen F; Xie W; Huang J; Lu N
Oncol Rep; 2019 Dec; 42(6):2245-2254. PubMed ID: 31578585
[TBL] [Abstract][Full Text] [Related]
20. APE1/Ref-1 regulates STAT3 transcriptional activity and APE1/Ref-1-STAT3 dual-targeting effectively inhibits pancreatic cancer cell survival.
Cardoso AA; Jiang Y; Luo M; Reed AM; Shahda S; He Y; Maitra A; Kelley MR; Fishel ML
PLoS One; 2012; 7(10):e47462. PubMed ID: 23094050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
